Melissa B. Epperly - 23 Jan 2025 Form 4 Insider Report for Roivant Sciences Ltd. (ROIV)

Reporting owner
Signature
By: /s/ Jo Chen, as Attorney-in-Fact for Melissa B. Epperly
Issuer context
Transaction snapshot
SEC evidence
Form type
4
Filing time
27 Jan 2025, 21:00:29 UTC
Previous filing
23 Oct 2024
Next filing
21 Apr 2025
SEC filing
View on sec.gov

Key filing fact

Melissa B. Epperly filed Form 4 for Roivant Sciences Ltd. (ROIV) on 27 Jan 2025.

Key facts

  • This page summarizes Melissa B. Epperly's Form 4 filing for Roivant Sciences Ltd. (ROIV).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Filing timestamp: 27 Jan 2025, 21:00.

Change

  • Previous filing in this sequence was filed on 23 Oct 2024.
  • Current net transaction value: -$2,018.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reported transactions

ROIV transaction

Common Shares

Award

Transaction value
$0
Shares
+1,672
Change %
+4.4%
Price
$0.000000
Shares after
39,709
Date
23 Jan 2025
Ownership
Direct
Footnotes
F1
ROIV transaction

Common Shares

Tax liability

Transaction value
$2,018
Shares
-180
Change %
-0.45%
Price
$11.21
Shares after
39,529
Date
23 Jan 2025
Ownership
Direct
Footnotes
F2
* indicates a reported price that failed the local validity check.

Explanation of Responses:

Id Content
F1 Reflects an award of Common Shares received pursuant to the Issuer's Non-Employee Director Compensation Plan that was fully vested as of the grant date.
F2 Represents the "net settlement" by the Issuer of Common Shares previously granted to the reporting person pursuant to the Issuer's Non-Employee Director Compensation Plan in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such Common Shares.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .